| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228335 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 9 Pages |
Abstract
Combination of intratumoral DC administration with EBRT was safe and resulted in induction of antitumor immune responses. This suggests that this therapy is promising and needs further testing in clinical trials design to assess clinical efficacy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Steven E. M.D., Cristina Ph.D., Marilyn M. M.D., Matthew J. Ph.D., Rupal Ph.D., Jamil B.S., David R. Ph.D., David M.D., Ricardo J. M.D., Randy V. M.D., Claudia M.D., Brianna C. B.S., William Ph.D., Jonathan S. M.D., Vernon K. M.D., G. Douglas M.D.,